Abstract
This article provides a summary of main messages of the annual Steve Hudson memorial lecture presented by Tobias Dreischulte at the 42nd European Society of Clinical Pharmacy symposium in Prague in 2013. An exploration of what is meant by integrated pharmaceutical care, the design and pilot testing of a model for continuous quality improvement of medication use designed to facilitate care integration, and opportunities and challenges of implementing the model in practice are discussed.
Similar content being viewed by others
References
European Society of Cardiology. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.
Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.
Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2006;63(2):136–47.
Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–6.
Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2007;17:109–16.
Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21 century. Washington, DC: National Academy Press; 2001.
Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1999;8(1):2–4.
Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.
Bryant LJM, Coster G, Gamble GD, et al. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. Int J Pharm Pract. 2011;19(2):94–105.
Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract. 2007;24(2):189–200.
Dreischulte T, Grant A, McCowan C, et al. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol. 2012;12(1):5.
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.
Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714–20.
Gallagher P, Ryan C, Byrne S, et al. Screening tool of older persons’ potentially inappropriate prescriptions (STOPP) and screening tool to alert doctors to right treatment (START): validation and application to hospitalised elderly patients. Age Ageing. 2008;37:56.
Dreischulte T, Johnson J, McAnaw J, et al. Medication assessment tool to detect care issues from routine data: a pilot study in primary care. Int J Clin Pharm. doi:10.1007/s11096-013-9828-2 [Epub 20 Aug 2013].
Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–81.
Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569–82.
Machado M, Nassor N, Bajcar JM, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42(9):1195–207.
Dreischulte T, Grant A, Donnan P, et al. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: the DQIP study protocol. Implement Sci. 2012;7(1):24.
Avery A, Rodgers S, Cantrill J, et al. Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices. Trials. 2009;10(1):28.
Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1310–9.
Disclosure
During the preparation of this article, the author was supported by the Scottish government health directorates chief scientist office applied research programme grant 07/02.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dreischulte, T. Integrated pharmaceutical care in the community: (how) can we turn vision into reality?. Drugs Ther Perspect 30, 65–71 (2014). https://doi.org/10.1007/s40267-013-0095-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-013-0095-z